© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jul 18, 2014, the consensus forecast amongst 50 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 24 analysts offering 12 month price targets for
|Div growth (TTM)||+5.41%|
On Apr 30, 2014,
The next earnings announcement is expected on Jul 23, 2014. View Full Interim Financials
|Average growth rate||-4.46%|
|Average growth rate||-1.42%|
GlaxoSmithKline plc had 1st quarter 2014 revenues of 5.61bn. This missed the 5.82bn consensus estimate of the 9 analysts following the company. This was 18.72% below the prior year's 1st quarter results. View Full Interim Financials
|Average growth rate||-3.00%|
GlaxoSmithKline plc had revenues for the full year 2013 of 26.51bn. This was 0.28% above the prior year's results. View Full Annual Financials
|Average growth rate||-1.67%|